• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体和 MYC 转录组在前列腺癌的多层调控回路中达到平衡。

Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer.

机构信息

Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, P.R.China.

Department of Medicine, Hematology-Oncology Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachussetts, USA.

出版信息

Prostate. 2023 Nov;83(15):1415-1429. doi: 10.1002/pros.24603. Epub 2023 Aug 11.

DOI:10.1002/pros.24603
PMID:37565264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10529406/
Abstract

BACKGROUND

The discovery of androgen receptor (AR) having transrepression effects completes the circle of its functionalities as a typical transcription factor, which intrinsically bears dual functions of activation and repression linked to co-factor competition and redistribution. Indeed, AR dual functions are exemplified by locus-wide regulation of the oncogenic 8q24-MYC region.

METHODS

RT-qPCR assay and public RNA-profiling datasets were used to assess MYC transcription in androgen-sensitive cell lines. Public ChIP-seq and RNA-Seq datasets were computed to evaluate AR-MYC direct and indirect signatures. Gene sets in typical MYC and AR pathways were monitored to validate their cross-talks. Bio-informatics and chromosome conformation capture (3C) assay were performed in the AR gene locus to examine androgen-elicited distal regulation. Finally, co-factor re-distribution were globally tracked between AR and MYC binding sites.

RESULTS

In this report, we found MYC responded negatively to androgen with hypersensitivity, rivaling AR natural functions as an innate androgen effector. Furthermore, both direct and indirect AR and MYC transcriptional programs were actively in equilibration. With established androgen-mediated versus MYC-mediated gene subsets, we validated AR and MYC pathways were both bidirectional and extensively entangled. In addition, we determined that the AR gene locus resembled the MYC gene region and both loci were androgen-repressed via epigenetics and chromatin architectural alterations. Significantly, transcriptional factor profiling along the prostate cancer (PCa) genome exposed that PCa transcriptomes were dynamically equilibrated between AR-binding site and MYC-binding site.

CONCLUSION

Together, our findings stratified AR-MYC interactions that are extensively wired and intricately organized to compensate for essential PCa transcriptional programs and neutralize excessive signaling.

摘要

背景

雄激素受体(AR)具有反式转录抑制作用的发现,使其作为典型的转录因子的功能趋于完整,其内在的激活和抑制功能与共因子的竞争和再分配有关。事实上,AR 的双重功能在致癌 8q24-MYC 区域的全基因座调节中得到了例证。

方法

采用 RT-qPCR 检测和公共 RNA 谱数据集来评估雄激素敏感细胞系中 MYC 的转录。计算公共 ChIP-seq 和 RNA-Seq 数据集,以评估 AR-MYC 的直接和间接特征。监测典型的 MYC 和 AR 通路中的基因集,以验证它们的相互作用。在 AR 基因座中进行生物信息学和染色体构象捕获(3C)检测,以检查雄激素诱导的远端调节。最后,在 AR 和 MYC 结合位点之间全面跟踪共因子的再分布。

结果

在本报告中,我们发现 MYC 对雄激素的反应呈超敏性,与 AR 作为天然雄激素效应物的自然功能相抗衡。此外,AR 和 MYC 的直接和间接转录程序都在积极平衡。通过建立雄激素介导的与 MYC 介导的基因子集,我们验证了 AR 和 MYC 通路都是双向的,并且广泛交织。此外,我们确定 AR 基因座类似于 MYC 基因区域,并且通过表观遗传学和染色质结构改变,两个基因座都被雄激素抑制。重要的是,沿着前列腺癌(PCa)基因组的转录因子分析表明,PCa 转录组在 AR 结合位点和 MYC 结合位点之间动态平衡。

结论

总的来说,我们的研究结果分层了 AR-MYC 相互作用,这些相互作用广泛连接且组织复杂,以补偿关键的 PCa 转录程序并中和过度的信号传导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/abe5f7096bb4/nihms-1920172-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/464df7138a47/nihms-1920172-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/aa5f6dd9ae8f/nihms-1920172-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/1437a7f6df07/nihms-1920172-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/a2e009e089ba/nihms-1920172-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/c5592ebe65e1/nihms-1920172-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/abe5f7096bb4/nihms-1920172-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/464df7138a47/nihms-1920172-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/aa5f6dd9ae8f/nihms-1920172-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/1437a7f6df07/nihms-1920172-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/a2e009e089ba/nihms-1920172-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/c5592ebe65e1/nihms-1920172-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d7c/10529406/abe5f7096bb4/nihms-1920172-f0006.jpg

相似文献

1
Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer.雄激素受体和 MYC 转录组在前列腺癌的多层调控回路中达到平衡。
Prostate. 2023 Nov;83(15):1415-1429. doi: 10.1002/pros.24603. Epub 2023 Aug 11.
2
Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions.解析前列腺癌中 8q24-MYC 基因座的转录,认识到雄激素受体直接和间接双重功能之间的平衡。
J Transl Med. 2023 Oct 12;21(1):716. doi: 10.1186/s12967-023-04429-4.
3
Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.雄激素受体和 MYC 平衡集中在发育超级增强子上。
Nat Commun. 2021 Dec 15;12(1):7308. doi: 10.1038/s41467-021-27077-y.
4
c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.c-Myc 拮抗前列腺癌细胞中雄激素受体的转录活性,影响关键基因网络。
EBioMedicine. 2017 Apr;18:83-93. doi: 10.1016/j.ebiom.2017.04.006. Epub 2017 Apr 5.
5
Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA.雄激素受体(AR)编码区域中的多个雄激素反应元件和一个Myc共有序列位点参与雄激素介导的AR信使核糖核酸的上调。
Mol Endocrinol. 1999 Nov;13(11):1896-911. doi: 10.1210/mend.13.11.0369.
6
The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cells.miRNAs 203a/210-3p/5001-5p 调节雄激素/雄激素受体/YAP 诱导的前列腺癌细胞迁移。
Cancer Med. 2024 Aug;13(16):e70106. doi: 10.1002/cam4.70106.
7
FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.FOXP1是一种雄激素反应性转录因子,它在前列腺癌细胞中负向调节雄激素受体信号传导。
Biochem Biophys Res Commun. 2008 Sep 19;374(2):388-93. doi: 10.1016/j.bbrc.2008.07.056. Epub 2008 Jul 18.
8
Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.NKX3-1 整合调控网络促进雄激素依赖性前列腺癌的存活。
Mol Cell Biol. 2012 Jan;32(2):399-414. doi: 10.1128/MCB.05958-11. Epub 2011 Nov 14.
9
Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.威尔姆斯肿瘤抑制基因WT1对雄激素信号通路的转录调控。
Anticancer Res. 2001 Jan-Feb;21(1A):1-10.
10
MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.微小RNA137是雄激素调节的转录共调节因子扩展网络的一种阻遏物。
Oncotarget. 2015 Nov 3;6(34):35710-25. doi: 10.18632/oncotarget.5958.

引用本文的文献

1
Epigenetic remodeling by sex hormone receptors and implications for gender affirming hormone therapy.性激素受体介导的表观遗传重塑及其对性别肯定激素治疗的影响。
Front Immunol. 2025 May 8;16:1501959. doi: 10.3389/fimmu.2025.1501959. eCollection 2025.

本文引用的文献

1
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC.雄激素受体在前列腺癌中的活性通过 MYC 决定了双极雄激素治疗的疗效。
J Clin Invest. 2022 Dec 1;132(23):e162396. doi: 10.1172/JCI162396.
2
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets.MYC 通过扰乱雄激素受体靶基因的转录暂停释放来驱动侵袭性前列腺癌。
Nat Commun. 2022 May 13;13(1):2559. doi: 10.1038/s41467-022-30257-z.
3
Therapeutic targeting of "undruggable" MYC.靶向“不可成药” MYC 的治疗策略。
EBioMedicine. 2022 Jan;75:103756. doi: 10.1016/j.ebiom.2021.103756. Epub 2021 Dec 20.
4
Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.雄激素受体和 MYC 平衡集中在发育超级增强子上。
Nat Commun. 2021 Dec 15;12(1):7308. doi: 10.1038/s41467-021-27077-y.
5
ONECUT2 is a driver of neuroendocrine prostate cancer.ONECUT2 是神经内分泌前列腺癌的驱动基因。
Nat Commun. 2019 Jan 17;10(1):278. doi: 10.1038/s41467-018-08133-6.
6
The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.MYC增强子组:癌症中MYC的远程转录调控
Trends Cancer. 2018 Dec;4(12):810-822. doi: 10.1016/j.trecan.2018.10.003. Epub 2018 Nov 2.
7
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.转移性前列腺癌的基因组特征和结构变异。
Cell. 2018 Jul 26;174(3):758-769.e9. doi: 10.1016/j.cell.2018.06.039. Epub 2018 Jul 19.
8
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer.雄激素受体获得性增强子是晚期前列腺癌的非编码驱动因素。
Cell. 2018 Jul 12;174(2):422-432.e13. doi: 10.1016/j.cell.2018.05.037. Epub 2018 Jun 14.
9
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing.通过链接读取基因组测序揭示推动去势抵抗性前列腺癌的结构改变。
Cell. 2018 Jul 12;174(2):433-447.e19. doi: 10.1016/j.cell.2018.05.036. Epub 2018 Jun 18.
10
Characterization of novel cell lines derived from a MYC-driven murine model of lethal metastatic adenocarcinoma of the prostate.源自MYC驱动的前列腺致死性转移性腺癌小鼠模型的新型细胞系的特征分析。
Prostate. 2018 Sep;78(13):992-1000. doi: 10.1002/pros.23657. Epub 2018 May 30.